Full Professor(heuristic)

Cancer-related gene regulation · Molecular Biology

Compare more Molecular Biology professors.

h-index89
i10-index203
Publications365
Citations26,651

Grants

15 total · 4 active

NIH #R25CA181004

MD Anderson Summer Program in Cancer Research (SPCR)

Active
Amount
$200K–$300K
Period
2014-08-11 → 2030-03-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R35GM153387

A Functional Analysis of Arginine Methylation

Active
Amount
$400K–$500K
Period
2024-09-01 → 2029-07-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA272843

Mechanisms of action and therapeutic targeting of the CARM1-NFIB axis in small cell lung cancer

Active
Amount
$600K–$700K
Period
2023-07-01 → 2028-06-30
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

15 total · 4 active

NIH #R25CA181004

MD Anderson Summer Program in Cancer Research (SPCR)

Active
Amount
$200K–$300K
Period
2014-08-11 → 2030-03-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R35GM153387

A Functional Analysis of Arginine Methylation

Active
Amount
$400K–$500K
Period
2024-09-01 → 2029-07-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA272843

Mechanisms of action and therapeutic targeting of the CARM1-NFIB axis in small cell lung cancer

Active
Amount
$600K–$700K
Period
2023-07-01 → 2028-06-30
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21CA296234

Exploratory studies of cellular resistance to MTA-cooperative PRMT5 inhibitors in MTAP-loss tumors.

Active
Amount
$400K–$500K
Period
2025-08-01 → 2027-07-31
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NSF #1939814

NSF/MCB-BSF: TWIST1 post-translational modification crosstalk in EMT

Amount
$700K–$800K
Period
2020-03-01 → 2024-08-31
PIs
1

Awarded at University of Texas, M.D. Anderson Cancer Center

NIH #R01GM126421

The Functional Analysis of the Coactivator CARM1

Amount
$300K–$400K
Period
2002-08-01 → 2022-08-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01ES023206

Epigenetic Programmers Targeted During Developmental Reprogramming

Amount
$500K–$600K
Period
2013-09-01 → 2017-05-31
PIs
4

Awarded at TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR

NIH #R01DK062248

The Functional Analysis of the Coactivator CARM1

Amount
$300K–$400K
Period
2002-08-01 → 2016-08-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R03DA031087

Identify small molecule inhibitors of methyl-dependent protein-protein interactio

Amount
<$100K
Period
2010-06-15 → 2012-05-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21DA025800

Applying peptide and protein domain microarrays to epigenetic research

Amount
$300K–$400K
Period
2008-09-20 → 2010-07-31
PIs
2

Awarded at STANFORD UNIVERSITY

NIH #R21ES015188

Regulation of Transcriptional Coactivators by Environmental Estrogens (R21)

Amount
$200K–$300K
Period
2006-09-26 → 2010-05-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21DA023449

Identifying and Characterizing Readers of the Neural Histone Code

Amount
$100K–$200K
Period
2007-09-20 → 2009-08-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA114116

Small Molecule Regulators of Arginine Methyltransferases

Amount
$200K–$300K
Period
2005-04-01 → 2008-03-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R56DK062248

The Functional Analysis of the Coactivator CARM1

Amount
<$100K
Period
2002-08-01 → 2007-09-29
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R41GM068996

Protein Array Technology for Protein Interaction

Amount
$100K–$200K
Period
2003-08-01 → 2004-07-31
PIs
1

Awarded at PANOMICS, INC.

Recent Public Signals

  1. New paper: Abstract P49: Target PRMTs to Overcome Cancer Immune Resistance (Cancer Research)2026-07-02
  2. New preprint: Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer2026-04-21
  3. New NIH award: Exploratory studies of cellular resistance to MTA-cooperative PRMT5 inhibitors in MTAP-loss tumors.2025-08-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-8899-1050

Professor Insights

Career Trajectory